MDXG

NASD MiMedx Group, Inc.

Nov 10, 2026 · 11:10 PM ET EOD Market Closed

$3.37 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.37, $0.04 below the day’s high of $3.41

YTD change: -50.22%
vs 20-day SMA: -13.46%
vs 200-day SMA: -19.90%

Price ranges

Previous day

$3.22 $3.37

open $3.31 close $3.32

+$0.01 (+0.30%)

Today

$3.26 $3.41

open $3.30 now $3.37

+$0.07 (+2.12%)

Past week

$3.05 $3.44

from $3.28 now $3.37

+$0.09 (+2.74%)

Past month

$3.05 $4.88

from $4.83 now $3.37

-$1.46 (-30.23%)

This year

$3.03 $6.79

from $6.77 now $3.37

-$3.40 (-50.22%)

Price & Performance

-0.19 (-5.34%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 81.5% away from all-time highs of $18.25
MDXG is down 50% since the beginning of the year
MDXG is down 56% over the past 12 months
MDXG is down 30% over the past 1 month
8% of all MDXG investors are betting against MDXG

MDXG reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -56.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.06

Earnings momentum +475.0% Quarterly EPS growth

Quarterly change +475.0%

Valuation

P/E ratio N/A

Enterprise value $363.5M

Beta 1.28

Balance sheet & scale

IncomeN/A

Revenue$303.7M

Cash$120.8M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $491.8M

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Competitor comparison

Ticker	Company	Price	Change
JNJ.CAT	JOHNSON & JOHNSON CIBC CDR C REG S	$35.71	-0.50%
BDX	Becton, Dickinson and Company	$212.61	-1.23%
MDLN	Medline, Inc. Class A	$40.91	+0.49%
DXCM	DexCom, Inc.	$79.92	-1.42%
WST	West Pharmaceutical Services, Inc.	$412.55	-0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.